Fibroblast growth factor-21, energy balance and obesity

Molecular and Cellular Endocrinology

Volumn 418, Issue , 2015, Pages 66-73

  Giralt, Marta ^a   Gavaldà Navarro, Aleix ^a   Villarroya, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Brown adipose tissue; Energy expenditure; FGF21; White adipose tissue

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE TRANSPORTER 1; KLOTHO PROTEIN; UNCOUPLING PROTEIN 1; FIBROBLAST GROWTH FACTOR;

ADRENERGIC SYSTEM; ARTICLE; BROWN ADIPOSE TISSUE; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; GLYCATION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONSHIVERING THERMOGENESIS; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION; ANIMAL; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 84946739962     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.09.018     Document Type: Article

References (115)

1. Adams A.C., Astapova I., Fisher F.M., Badman M.K., Kurgansky K.E., Flier J.S., et al. Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner. J. Biol. Chem. 2010, 285:14078-14082.
2. Adams A.C., Yang C., Coskun T., Cheng C.C., Gimeno R.E., Luo Y., et al. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol. Metab. 2012, 2:31-37.
3. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007, 5:426-437.
4. Bauwens M., Wierts R., van Royen B., Bucerius J., Backes W., Mottaghy F., et al. Molecular imaging of brown adipose tissue in health and disease. Eur. J. Nucl. Med. Mol. Imaging 2014, 41:776-791.
5. Bobbert T., Schwarz F., Fischer-Rosinsky A., Pfeiffer A.F., Mohlig M., Mai K., et al. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care 2013, 36:145-149.
6. Bookout A.L., de Groot M.H., Owen B.M., Lee S., Gautron L., Lawrence H.L., et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat. Med. 2013, 19:1147-1152.
7. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 1994, 84:277-359.
8. Chartoumpekis D.V., Habeos I.G., Ziros P.G., Psyrogiannis A.I., Kyriazopoulou V.E., Papavassiliou A.G. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol. Med. 2011, 17:736-740.
9. Chau M.D., Gao J., Yang Q., Wu Z., Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc. Natl. Acad. Sci. 2010, 107:12553-12558.
10. Chavez A.O., Molina-Carrion M., Abdul-Ghani M.A., Folli F., DeFronzo R.A., Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care 2009, 32:1542-1546.
11. Chen C., Cheung B.M., Tso A.W., Wang Y., Law L.S., Ong K.L., et al. High plasma level of fibroblast growth factor 21 is an independent predictor of type 2 diabetes: a 54-year population-based prospective study in Chinese subjects. Diabetes Care 2011, 34:2113-2115.
12. Chu A.Y., Workalemahu T., Paynter N.P., Rose L.M., Giulianini F., Tanaka T., et al. Novel locus including FGF21 is associated with dietary macronutrient intake. Hum. Mol. Genet. 2013, 22:1895-1902.
13. Coskun T., Bina H.A., Schneider M.A., Dunbar J.D., Hu C.C., Chen Y., et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008, 149:6018-6027.
14. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
15. Cypess A.M., White A.P., Vernochet C., Schulz T.J., Xue R., Sass C.A., et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 2013, 19:635-639.
16. De Sousa-Coelho A.L., Marrero P.F., Haro D. Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem. J. 2012, 443:165-171.
17. De Sousa-Coelho A.L., Relat J., Hondares E., Perez-Marti A., Ribas F., Villarroya F., et al. FGF21 mediates the lipid metabolism response to amino acid starvation. J. Lipid Res. 2013, 54:1786-1797.
18. Del Mar Gonzalez-Barroso M., Ricquier D., Cassard-Doulcier A.M. The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research. Obes. Rev. 2000, 1:61-72.
19. Díaz-Delfín J., Hondares E., Iglesias R., Giralt M., Caelles C., Villarroya F. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology 2012, 153:4238-4245.
20. Ding X., Boney-Montoya J., Owen B.M., Bookout A.L., Coate K.C., Mangelsdorf D.J., et al. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 2012, 16:387-393.
21. Domingo P., Gallego-Escuredo J.M., Domingo J.C., Gutiérrez Mdel M., Mateo M.G., Fernández I., et al. Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients. AIDS 2010, 24:2629-2637.
22. Domouzoglou E.M., Fisher F.M., Astapova I., Fox E.C., Kharitonenkov A., Flier J.S., et al. Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo. Endocrinology 2014, 155:2031-2040.
23. Dong J.Q., Rossulek M., Somayaji V.R., Baltrukonis D., Liang Y., Hudson K., et al. Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study. Br. J. Clin. Pharmacol. 2015, [Epub ahead of print] PMID: 25940675. 10.1111/bcp.12676.
24. Douris N., Stevanovic D.M., Fisher F.M., Cisu T.I., Chee M.J., Nguyen N.L., et al. Central fibroblast growth factor 21 browns white fat via sympathetic action in male mice. Endocrinology 2015, 156:2470-2481.
25. Dushay J., Chui P.C., Gopalakrishnan G.S., Varela-Rey M., Crawley M., Fisher F.M., et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010, 139:456-463.
26. Emanuelli B., Vienberg S.G., Smyth G., Cheng C., Stanford K.I., Arumugam M., et al. Interplay between FGF21 and insulin action in the liver regulates metabolism. J. Clin. Invest. 2014, 124:515-527.
27. Enerbäck S., Jacobsson A., Simpson E.M., Guerra C., Yamashita H., Harper M.E., et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997, 387:90-94.
28. Feldmann H.M., Golozoubova V., Cannon B., Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 2009, 9:203-209.
29. Fisher F.M., Chui P.C., Antonellis P.J., Bina H.A., Kharitonenkov A., Flier J.S., et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010, 59:2781-2789.
30. Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012, 26:271-281.
31. Foltz I.N., Hu S., King C., Wu X., Yang C., Wang W., et al. Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex. Sci. Transl. Med. 2012, 4. 162ra153.
32. FonTacer K., Bookout A.L., Ding X., Kurosu H., John G.B., Wang L., et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 2010, 24:2050-2064.
33. Gaich G., Chien J.Y., Fu H., Glass L.C., Deeg M.A., Holland W.L., et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013, 18:333-340.
34. Gallego-Escuredo J.M., Domingo P., Gutiérrez Mdel M., Mateo M.G., Cabeza M.C., Fontanet A., et al. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients. J. Acquir. Immune. Defic. Syndr. 2012, 61:527-534.
35. Gallego-Escuredo J.M., Gómez-Ambrosi J., Catalan V., Domingo P., Giralt M., Frühbeck G., et al. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int. J. Obes. Lond. 2015, 39:121-129.
36. Ge X., Chen C., Hui X., Wang Y., Lam K.S., Xu A. Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes. J. Biol. Chem. 2011, 286:34533-34541.
37. Giralt M., Villarroya F. White, brown, beige/brite: different adipose cells for different functions?. Endocrinology 2013, 154:2992-3000.
38. Goetz R., Beenken A., Ibrahimi O.A., Kalinina J., Olsen S.K., Eliseenkova A.V., et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 2007, 27:3417-3428.
39. Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974, 249:123-127.
40. Gotoh N. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci. 2008, 99:1319-1325.
41. Habegger K.M., Stemmer K., Cheng C., Müller T.D., Heppner K.M., Ottaway N., et al. Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 2013, 62:1453-1463.
42. Hale C., Chen M.M., Stanislaus S., Chinookoswong N., Hager T., Wang M., et al. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 2012, 153:69-80.
43. Hanssen M.J., Broeders E., Samms R.J., Vosselman M.J., van der Lans A.A., Cheng C.C., et al. Serum FGF21 levels are associated with brown adipose tissue activity in humans. Sci. Rep. 2015, 5:10275.
44. Hondares E., Rosell M., Gonzalez F.J., Giralt M., Iglesias R., Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab. 2010, 11:206-212.
45. Hondares E., Iglesias R., Giralt A., Gonzalez F.J., Giralt M., Mampel T., et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J. Biol. Chem. 2011, 286:12983-12990.
46. Hondares E., Gallego-Escuredo J.M., Flachs P., Frontini A., Cereijo R., Goday A., et al. Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue. Metabolism 2014, 63:312-317.
47. Hotta Y., Nakamura H., Konishi M., Murata Y., Takagi H., Matsumura S., et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 2009, 150:4625-4633.
48. Hsuchou H., Pan W., Kastin A.J. The fasting polypeptide FGF21 can enter brain from blood. Peptides 2007, 28:2382-2386.
49. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005, 2:217-225.
50. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007, 5:415-425.
51. Ito S., Kinoshita S., Shiraishi N., Nakagawa S., Sekine S., Fujimori T., et al. Molecular cloning and expression analyses of mouse beta-klotho, which encodes a novel Klotho family protein. Mech. Dev. 2000, 98:115-119.
52. Izumiya Y., Bina H.A., Ouchi N., Akasaki Y., Kharitonenkov A., Walsh K. FGF21 is an Akt-regulated myokine. FEBS Lett. 2008, 582:3805-3810.
53. Jespersen N.Z., Larsen T.J., Peijs L., Daugaard S., Homøe P., Loft A., et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab. 2013, 17:798-805.
54. Keipert S., Kutschke M., Lamp D., Brachthäuser L., Neff F., Meyer C.W., et al. Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion. Mol. Metab. 2015, 4:537-542.
55. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 2005, 115:1627-1635.
56. Kharitonenkov A., Wroblewski V.J., Koester A., Chen Y.F., Clutinger C.K., Tigno X.T., et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007, 148:774-781.
57. Kim H., Mendez R., Zheng Z., Chang L., Cai J., Zhang R., et al. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21. Endocrinology 2014, 155:769-782.
58. Kouhara H., Hadari Y.R., Spivak-Kroizman T., Schilling J., Bar-Sagi D., Lax I., et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 1997, 89:693-702.
59. Kurosu H., Choi M., Ogawa Y., Dickson A.S., Goetz R., Eliseenkova A.V., et al. Tissue-specific expression of beta-Klotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 2007, 282:26687-26695.
60. Laeger T., Henagan T.M., Albarado D.C., Redman L.M., Bray G.A., Noland R.C., et al. FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 2014, 124:3913-3922.
61. Lamothe B., Yamada M., Schaeper U., Birchmeier W., Lax I., Schlessinger J. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Mol. Cell. Biol. 2004, 24:5657-5666.
62. Lean M.E.J., James P.T. Brown adipose tissue in man. Brown Adipose Tissue 1986, 339-365. Edward Arnold Ltd., London. P. Trayhurn, D.G. Nicholls (Eds.).
63. Lee P., Brychta R.J., Linderman J., Smith S., Chen K.Y., Celi F.S. Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis. J. Clin. Endocrinol. Metab. 2013, 98:E98-E102.
64. Lee P., Werner C.D., Kebebew E., Celi F.S. Functional thermogenic beige adipogenesis is inducible in human neck fat. Int. J. Obes. Lond. 2014, 38:170-176.
65. Lee P., Linderman J.D., Smith S., Brychta R.J., Wang J., Idelson C., et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014, 19:302-309.
66. Li Y., Wong K., Walsh K., Gao B., Zang M. Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice. J. Biol. Chem. 2013, 288:10490-10504.
67. Lidell M.E., Enerbäck S. Brown adipose tissue-a new role in humans?. Nat. Rev. Endocrinol. 2010, 6:319-325.
68. Liu S., Guo R., Simpson L.G., Xiao Z.S., Burnham C.E., Quarles L.D. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J. Biol. Chem. 2003, 278:37419-37426.
69. López M., Varela L., Vázquez M.J., Rodríguez-Cuenca S., González C.R., Velagapudi V.R., et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 2010, 16:1001-1008.
70. Lowell B.B., S-Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
71. Lundasen T., Hunt M.C., Nilsson L.M., Sanyal S., Angelin B., Alexson S.E., et al. PPARα is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 2007, 360:437-440.
72. Martínez de Morentin P.B., González-García I., Martins L., Lage R., Fernández-Mallo D., Martínez-Sánchez N., et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 2014, 20:41-53.
73. Mashili F.L., Austin R.L., Deshmukh A.S., Fritz T., Caidahl K., Bergdahl K., et al. Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 2011, 27:286-297.
74. Ming A.Y., Yoo E., Vorontsov E.N., Altamentova S.M., Kilkenny D.M., Rocheleau J.V. Dynamics and distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex. J. Biol. Chem. 2012, 287:19997-20006.
75. Mraz M., Bartlova M., Lacinova Z., Michalsky D., Kasalicky M., Haluzikova D., et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin. Endocrinol. 2009, 71:369-375.
76. Muise E.S., Azzolina B., Kuo D.W., El-Sherbeini M., Tan Y., Yuan X., et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol. Pharmacol. 2008, 74:403-412.
77. Nedergaard J., Bengtsson T., Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E444-E452.
78. Nygaard E.B., Møller C.L., Kievit P., Grove K.L., Andersen B. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta). Int. J. Obes. Lond. 2014, 38:183-191.
79. Nishimura T., Nakatake Y., Konishi M., Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 2000, 1492:203-206.
80. Owen B.M., Bookout A.L., Ding X., Lin V.Y., Atkin S.D., Gautron L., et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat. Med. 2013, 19:1153-1156.
81. Owen B.M., Ding X., Morgan D.A., Coate K.C., Bookout A.L., Rahmouni K., et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 2014, 20:670-677.
82. Planavila A., Redondo I., Hondares E., Vinciguerra M., Munts C., Iglesias R., et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat. Commun. 2013, 4:2019.
83. Planavila A., Redondo-Angulo I., Ribas F., Garrabou G., Casademont J., Giralt M., et al. Fibroblast growth factor 21 protects the heart from oxidative stress. Cardiovasc. Res. 2015, 106:19-31.
84. Reitman M.L. FGF21 mimetic shows therapeutic promise. Cell Metab. 2013, 18:307-309.
85. Ribas F., Villarroya J., Hondares E., Giralt M., Villarroya F. FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling. Biochem. J. 2014, 463:191-199.
86. Roesch S.L., Styer A.M., Wood G.C., Kosak Z., Seiler J., Benotti P., et al. Perturbations of fibroblast growth factors 19 and 21 in type 2 diabetes. PLoS One 2015, 10:e0116928.
87. Saito M., Okamatsu-Ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Nio-Kobayashi J., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009, 58:1526-1531.
88. Samms R.J., Smith D.P., Cheng C.C., Antonellis P.P., Perfield J.W., Kharitonenkov A., et al. Discrete aspects of FGF21 in vivo pharmacology do not require UCP1. Cell Rep. 2015, 11:991-999.
89. Sarruf D.A., Thaler J.P., Morton G.J., German J., Fischer J.D., Ogimoto K., et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010, 59:1817-1824.
90. Schaap F.G., Kremer A.E., Lamers W.H., Jansen P.L., Gaemers I.C. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. Biochimie 2013, 95:692-699.
91. Sharp L.Z., Shinoda K., Ohno H., Scheel D.W., Tomoda E., Ruiz L., et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One 2012, 7:e49452.
92. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. 2001, 98:6500-6505.
93. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 2004, 113:561-568.
94. Tan B.K., Hallschmid M., Adya R., Kern W., Lehnert H., Randeva H.S. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes 2011, 60:2758-2762.
95. Tomlinson E., Fu L., John L., Hultgren B., Huang X., Renz M., et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 2002, 143:1741-1747.
96. Tyynismaa H., Carroll C.J., Raimundo N., Ahola-Erkkilä S., Wenz T., Ruhanen H., et al. Mitochondrial myopathy induces a starvation-like response. Hum. Mol. Genet. 2010, 19:3948-3958.
97. Van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1500-1508.
98. Van Marken Lichtenbelt W. Brown adipose tissue and the regulation of nonshivering thermogenesis. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15:547-552.
99. Véniant M.M., Sivits G., Helmering J., Komorowski R., Lee J., Fan W., et al. Pharmacologic effects of FGF21 are independent of the "browning" of white adipose tissue. Cell Metab. 2015, 21:731-738.
100. Villarroya J., Cereijo R., Villarroya F. An endocrine role for brown adipose tissue?. Am. J. Physiol. Endocrinol. Metab. 2013, 305:E567-E572.
101. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 2009, 360:1518-1525.
102. Virtanen K.A., van Marken Lichtenbelt W.D., Nuutila P. Brown adipose tissue functions in humans. Biochim. Biophys. Acta 2013, 1831:1004-1008.
103. Wang H., Qiang L., Farmer S.R. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol. Cell. Biol. 2008, 28:188-200.
104. Wang Y., Solt L.A., Burris T.P. Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha. J. Biol. Chem. 2010, 285:15668-15673.
105. Wang W.F., Li S.M., Ren G.P., Zheng W., Lu Y.J., Yu Y.H. Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats. Endocrine 2015, 49:119-129.
106. Weng Y., Chabot J.R., Bernardo B., Yan Q., Zhu Y., Brenner M.B., et al. Pharmacokinetics (PK), pharmacodynamics (PD) and Integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice. PLoS One 2015, 10:e0119104.
107. Wente W., Efanov A.M., Brenner M., Kharitonenkov A., Köster A., Sandusky G.E., et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 2006, 55:2470-2478.
108. Wu J., Boström P., Sparks L.M., Ye L., Choi J.H., Giang A.H., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012, 150:366-376.
109. Xu J., Lloyd D.J., Hale C., Stanislaus S., Chen M., Sivits G., et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009, 58:250-259.
110. Yang C., Jin C., Li X., Wang F., McKeehan W.L., Luo Y. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. PLoS One 2012, 7:e33870.
111. Ye X., Qi J., Ren G., Xu P., Wu Y., Zhu S., et al. Long-lasting anti-diabetic efficacy of PEGylatedFGF-21 and liraglutide in treatment of type 2 diabetic mice. Endocrine 2015, 49:683-692.
112. Yoneshiro T., Saito M. Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans. Ann. Med. 2014, 5:1-9.
113. Zhang X., Yeung D.C., Karpisek M., Stejskal D., Zhou Z.G., Liu F., et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008, 57:1246-1253.
114. Zhang M., Zeng L., Wang Y.J., An Z.M., Ying B.W. Associations of fibroblast growth factor 21 gene 3' untranslated region single-nucleotide polymorphisms with metabolic syndrome, obesity, and diabetes in a Han Chinese population. DNA Cell Biol. 2012, 31:547-552.
115. Zhang A., Sieglaff D.H., York J.P., Suh J.H., Ayers S.D., Winnier G.E., et al. Thyroid hormone receptor regulates most genes independently of fibroblast growth factor 21 in liver. J. Endocrinol. 2015, 224:289-301.